Health
Global big pharma M&A explodes; Q1 2026 deals hit $84B, double YoY
2026 Q1 biotech M&A surged to $84B from $44.4B YoY. Sun Pharma-Organon $11.75B, Bayer-Perfuse $2.45B lead deals. Full-year 2026 forecast $250B+
Primary sources · 2
2026 Q1 biotech M&A surged to $84B from $44.4B YoY. Sun Pharma-Organon $11.75B, Bayer-Perfuse $2.45B lead deals. Full-year 2026 forecast $250B+
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.